MeSH tree: D02.455.426.392.368
A new study from the University of Wisconsin–Madison suggests that chemotherapy may not be reaching its full potential, in part because researchers and doctors have long misunderstood how some of the most common cancer drugs ...
Oct 27, 2023
0
160
Treatment with datopotamab deruxtecan (Dato-DXd), a novel Trop-2 directed antibody-drug conjugate, was found to significantly improve progression-free survival in patients with metastatic non-small cell lung cancer, an improvement ...
Oct 26, 2023
0
41
Patients with cancer whose oncologists receive payments from industry appear more likely to receive some non-recommended and low-value treatments, finds a US study published by The BMJ today.
Oct 25, 2023
0
37
A case study on ketamine reveals systemic barriers that prevent repurposing existing low-cost drugs like ketamine for treatment-resistant depression.
Oct 23, 2023
0
37
Nutrition is important for your whole body, including those two small organs through which you look at the world.
Oct 20, 2023
0
113
In study after study, the psychoactive drug ketamine has given profound and fast relief to many people suffering from severe depression. But these studies have a critical shortcoming: Participants usually can tell whether ...
Oct 19, 2023
2
234
Research led by the Dana Farber Cancer Institute, Massachusetts, performed a secondary analysis of the Dana-Farber Cancer Institute 05-043 trial. In the paper, "Risk of Short-Term Prostate-Specific Antigen Recurrence and ...
The fall harvests usher in loads of pumpkins into grocery stores. But a smooth-skinned tropical fruit also vies for a consumer's attention: papaya.
Oct 16, 2023
0
39
The U.S. Food and Drug Administration is warning consumers about risks of using compounded versions of the drug ketamine, often taken for psychiatric disorders.
Oct 11, 2023
0
50
Cigarette makers are using synthetic menthol substitutes in what appears to be an effort to skirt a looming federal menthol ban, researchers say.
Oct 11, 2023
0
54
